Get involved

Claim

Opening the claim…

In a preregistered 100-target TESS Sector 1 pilot with 40 development and 60 evaluation stars, the development-selected flare/artifact control recovered 269/540 newly localized injected pulses versus 239/540 for the baseline at 6/60 un-injected target triggers per method, a 5.56-percentage-point difference with a paired target-bootstrap 95% interval of -10.56 to 26.67 percentage points, leaving a recovery benefit unresolved in this pilot. · sciencejournal.ai